Ascentage Pharma Group Stock Analysis
| ASPHF Stock | USD 8.48 0.00 0.00% |
Ascentage Pharma's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Ascentage Pharma's financial risk is the risk to Ascentage Pharma stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Ascentage Pharma's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Ascentage Pharma is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Ascentage Pharma to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Ascentage Pharma is said to be less leveraged. If creditors hold a majority of Ascentage Pharma's assets, the Company is said to be highly leveraged.
Ascentage Pharma Group is fairly valued with Real Value of 8.5 and Hype Value of 8.48. The main objective of Ascentage Pharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Ascentage Pharma Group is worth, separate from its market price. There are two main types of Ascentage Pharma's stock analysis: fundamental analysis and technical analysis.
The Ascentage Pharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ascentage Pharma's ongoing operational relationships across important fundamental and technical indicators.
Ascentage |
Ascentage Pink Sheet Analysis Notes
About 27.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.46. Ascentage Pharma had not issued any dividends in recent years. The quote for Ascentage Pharma Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Ascentage Pharma Group please contact the company at 86 512 8555 7777 or go to https://www.ascentagepharma.com.Ascentage Pharma Investment Alerts
| Ascentage Pharma generated a negative expected return over the last 90 days | |
| Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M. | |
| Ascentage Pharma generates negative cash flow from operations | |
| About 27.0% of the company shares are held by company insiders |
Ascentage Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ascentage Pharma's market, we take the total number of its shares issued and multiply it by Ascentage Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 9th of February, Ascentage Pharma shows the risk adjusted performance of (0.03), and Mean Deviation of 0.5103. Ascentage Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Ascentage Pharma risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Ascentage Pharma is priced correctly, providing market reflects its regular price of 8.48 per share. Given that Ascentage Pharma has variance of 5.82, we suggest you to validate Ascentage Pharma Group's prevailing market performance to make sure the company can sustain itself at a future point.Ascentage Pharma Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Ascentage Pharma price series with the more recent values given greater weights.
Ascentage Pharma Outstanding Bonds
Ascentage Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ascentage Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ascentage bonds can be classified according to their maturity, which is the date when Ascentage Pharma Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Ascentage Pharma Predictive Daily Indicators
Ascentage Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ascentage Pharma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Ascentage Pharma Forecast Models
Ascentage Pharma's time-series forecasting models are one of many Ascentage Pharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ascentage Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Ascentage Pharma Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Ascentage Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Ascentage Pharma, which in turn will lower the firm's financial flexibility.Ascentage Pharma Corporate Bonds Issued
Most Ascentage bonds can be classified according to their maturity, which is the date when Ascentage Pharma Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Ascentage Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Complementary Tools for Ascentage Pink Sheet analysis
When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |